Showing results (41-50 of 105) with videos related to
Sort By:
Pageof 11
Melanoma Research|April 27, 2019
Impact of initial stage on metastatic melanoma survivalMelissa A Wilson, Judy Zhong, Brooke E Rosenbaum, et al.Plos One|January 26, 2010
A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanomaPatrick A Ott, Anne Hamilton, Amanda Jones, et al.Melanoma Research|March 7, 2013
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgeryMaya Mathew, Moses Tam, Patrick A Ott, et al.Journal for Immunotherapy of Cancer|May 19, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysisMichael Lattanzi, Joseph Han, Una Moran, et al.Oncology|September 7, 2013
Impact of age on the management of primary melanoma patientsNathaniel H Fleming, Jiaying Tian, Eleazar Vega-Saenz de Miera, et al.The American Journal of Surgical Pathology|May 1, 2013
Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysisChristopher S Hale, Meng Qian, Michelle W Ma, et al.Plos One|January 12, 2012
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaMolly Yancovitz, Adam Litterman, Joanne Yoon, et al.JID Innovations : Skin Science From Molecules to Population Health|December 15, 2021
Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell CarcinomaGuilherme Rabinowits, Michael R Migden, Todd E Schlesinger, et al.Neuro-Oncology Advances|December 19, 2022
A multidisciplinary management algorithm for brain metastasesAlexander Ramos, Alexandra Giantini-Larsen, Susan C Pannullo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2009
Phosphorylated 4E-BP1 is associated with poor survival in melanomaKathryn E O'Reilly, Melanie Warycha, Michael A Davies, et al.Pageof 11